Literature DB >> 16250865

Fibrinolysis at the fluid-solid interface of thrombi.

K Kolev1, C Longstaff, R Machovich.   

Abstract

Thrombolysis is conventionally regarded as dissolution of the fibrin matrix of thrombi by plasmin, a protease generated by plasminogen activators from its inactive precursor, plasminogen. Typically plasminogen activation occurs on the surface of the clot, where fibrin behaves as a cofactor in this process, and plasmin also initiates its proteolytic action at the fluid-solid interface. Although the basic reactions of the plasminogen/plasmin system in fluid phase are well characterized in terms of classical enzymology, they cannot explain completely the interfacial fibrinolytic events. Recently new methods have been introduced for quantitative evaluation of plasminogen activation on gel-phase fibrin and heterogenous-phase proteolysis, an overview of the new methodology is presented. Following formation of an interfacial lytic zone, fibrin dissolution proceeds through propagation of this zone to the core of the clot, which depends on diffusion and permeation phenomena affected by the composition of thrombi. Phospholipids (originating from platelets) form a diffusion barrier to the thrombolytic agents and also bind some of them; structural cellular proteins (namely myosin) interact with the fibrin fibers masking their cofactor and plasmin-cleavage sites. The contribution of these recent findings to our understanding of the limitations of current thrombolytic therapy is discussed. Finally, attention is focused on the termination of thrombus-associated proteolytic action in an environment abundant in proteinase inhibitors. Thus, combining together the interfacial events in the initiation, progress and termination of thrombolysis, a concept for modeling the thrombus as a temporary fibrinolytic compartment is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16250865     DOI: 10.2174/156801605774322337

Source DB:  PubMed          Journal:  Curr Med Chem Cardiovasc Hematol Agents        ISSN: 1568-0169


  10 in total

1.  Factors affecting clot lysis rates in patients with spontaneous intraventricular hemorrhage.

Authors:  Wendy C Ziai; John Muschelli; Carol B Thompson; Penelope M Keyl; Karen Lane; Shuai Shao; Daniel F Hanley
Journal:  Stroke       Date:  2012-03-01       Impact factor: 7.914

2.  The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.

Authors:  Colin Longstaff; Craig Thelwell; Stella C Williams; Marta M C G Silva; László Szabó; Krasimir Kolev
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

3.  Effects of extracellular DNA on plasminogen activation and fibrinolysis.

Authors:  Andrey A Komissarov; Galina Florova; Steven Idell
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

Review 4.  Role of cellular elements in thrombus formation and dissolution.

Authors:  N Wohner
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-07

5.  Lytic and mechanical stability of clots composed of fibrin and blood vessel wall components.

Authors:  Z Rottenberger; E Komorowicz; L Szabó; A Bóta; Z Varga; R Machovich; C Longstaff; K Kolev
Journal:  J Thromb Haemost       Date:  2013-03       Impact factor: 5.824

6.  Hindered dissolution of fibrin formed under mechanical stress.

Authors:  I Varjú; P Sótonyi; R Machovich; L Szabó; K Tenekedjiev; M M C G Silva; C Longstaff; K Kolev
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

7.  Fibrinolysis in a lipid environment: modulation through release of free fatty acids.

Authors:  G Rábai; B Váradi; C Longstaff; P Sótonyi; V Kristóf; F Timár; R Machovich; K Kolev
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

Review 8.  Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review).

Authors:  Marzena Wyganowska-Świątkowska; Mateusz Tarnowski; Daniel Murtagh; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Med       Date:  2018-11-07       Impact factor: 4.101

9.  Suppressed catalytic efficiency of plasmin in the presence of long-chain fatty acids. Identification of kinetic parameters from continuous enzymatic assay with Monte Carlo simulation.

Authors:  Anna Tanka-Salamon; Kiril Tenekedjiev; Raymund Machovich; Krasimir Kolev
Journal:  FEBS J       Date:  2008-02-12       Impact factor: 5.542

10.  Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.

Authors:  András Kovács; László Szabó; Colin Longstaff; Kiril Tenekedjiev; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2013-09-21       Impact factor: 3.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.